Wells Fargo
BBH icon

Wells Fargo’s VanEck Biotech ETF BBH Stock Holding History

Wells Fargo’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.17M Buy
32,821
+3,464
+12% +$667K ﹤0.01% 2427
2025
Q4 		$5.56M Buy
29,357
+1,344
+5% +$249K ﹤0.01% 2579
2025
Q3 		$4.64M Buy
28,013
+542
+2% +$88.4K ﹤0.01% 2644
2025
Q2 		$4.21M Sell
27,471
-34,437
-56% -$5.13M ﹤0.01% 2608
2025
Q1 		$9.74M Sell
61,908
-13,918
-18% -$2.26M ﹤0.01% 1869
2024
Q4 		$11.9M Buy
75,826
+4,064
+6% +$684K ﹤0.01% 1725
2024
Q3 		$12.7M Buy
71,762
+3,198
+5% +$567K ﹤0.01% 1631
2024
Q2 		$11.5M Buy
68,564
+60,219
+722% +$9.85M ﹤0.01% 1607
2024
Q1 		$1.39M Buy
8,345
+225
+3% +$37.3K ﹤0.01% 3239
2023
Q4 		$1.34M Buy
8,120
+102
+1% +$15.7K ﹤0.01% 3227
2023
Q3 		$1.25M Sell
8,018
-1,618
-17% -$258K ﹤0.01% 3161
2023
Q2 		$1.5M Buy
9,636
+512
+6% +$81.8K ﹤0.01% 3140
2023
Q1 		$1.48M Buy
9,124
+1,020
+13% +$165K ﹤0.01% 3113
2022
Q4 		$1.29M Buy
8,104
+200
+3% +$31.7K ﹤0.01% 3085
2022
Q3 		$1.11M Buy
7,904
+1,846
+30% +$279K ﹤0.01% 3172
2022
Q2 		$883K Buy
6,058
+1,722
+40% +$256K ﹤0.01% 3363
2022
Q1 		$703K Sell
4,336
-4,073
-48% -$660K ﹤0.01% 4152
2021
Q4 		$1.59M Buy
8,409
+2,565
+44% +$495K ﹤0.01% 3714
2021
Q3 		$1.18M Buy
5,844
+162
+3% +$34K ﹤0.01% 4102
2021
Q2 		$1.15M Sell
5,682
-427
-7% -$79.5K ﹤0.01% 4121
2021
Q1 		$1.07M Buy
6,109
+90
+1% +$16.3K ﹤0.01% 4196
2020
Q4 		$1.02M Sell
6,019
-582
-9% -$95.9K ﹤0.01% 4008
2020
Q3 		$1.07M Buy
6,601
+628
+11% +$102K ﹤0.01% 3807
2020
Q2 		$974K Buy
5,973
+1,007
+20% +$153K ﹤0.01% 3838
2020
Q1 		$635K Sell
4,966
-813
-14% -$110K ﹤0.01% 3861
2019
Q4 		$806K Sell
5,779
-1,009
-15% -$133K ﹤0.01% 4004
2019
Q3 		$801K Sell
6,788
-44
-0.6% -$5.47K ﹤0.01% 4014
2019
Q2 		$881K Sell
6,832
-7,007
-51% -$864K ﹤0.01% 3948
2019
Q1 		$1.78M Sell
13,839
-1,493
-10% -$189K ﹤0.01% 3460
2018
Q4 		$1.7M Buy
15,332
+10,525
+219% +$1.27M ﹤0.01% 3400
2018
Q3 		$654K Sell
4,807
-1,000
-17% -$130K ﹤0.01% 4255
2018
Q2 		$697K Buy
5,807
+1,674
+41% +$197K ﹤0.01% 4230
2018
Q1 		$498K Sell
4,133
-2,978
-42% -$374K ﹤0.01% 4387
2017
Q4 		$887K Buy
7,111
+2,151
+43% +$275K ﹤0.01% 4018
2017
Q3 		$665K Sell
4,960
-533
-10% -$69.4K ﹤0.01% 4136
2017
Q2 		$690K Sell
5,493
-1,202
-18% -$145K ﹤0.01% 4005
2017
Q1 		$796K Sell
6,695
-14,461
-68% -$1.69M ﹤0.01% 3917
2016
Q4 		$2.27M Buy
21,156
+16,557
+360% +$1.8M ﹤0.01% 3056
2016
Q3 		$530K Sell
4,599
-991
-18% -$113K ﹤0.01% 3920
2016
Q2 		$573K Buy
5,590
+550
+11% +$58.7K ﹤0.01% 3832
2016
Q1 		$523K Sell
5,040
-13,773
-73% -$1.44M ﹤0.01% 3841
2015
Q4 		$2.39M Sell
18,813
-910
-5% -$111K ﹤0.01% 2853
2015
Q3 		$2.25M Sell
19,723
-4,183
-17% -$554K ﹤0.01% 2908
2015
Q2 		$3.22M Sell
23,906
-243
-1% -$32.3K ﹤0.01% 2730
2015
Q1 		$3.13M Buy
24,149
+3,189
+15% +$401K ﹤0.01% 2715
2014
Q4 		$2.42M Buy
20,960
+2,382
+13% +$268K ﹤0.01% 2875
2014
Q3 		$1.97M Buy
18,578
+8,998
+94% +$910K ﹤0.01% 3016
2014
Q2 		$914K Sell
9,580
-171
-2% -$15.3K ﹤0.01% 3585
2014
Q1 		$887K Buy
9,751
+5,431
+126% +$528K ﹤0.01% 3581
2013
Q4 		$383K Buy
4,320
+720
+20% +$60.2K ﹤0.01% 3934
2013
Q3 		$298K Hold
3,600
– – ﹤0.01% 4009
2013
Q2 		$247K Buy
+3,600
New +$250K ﹤0.01% 4038

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
PPWM
Paragon Private Wealth Management Lexington, Kentucky $383M AUM 36.18% 1-Year Est. Return

Wells Fargo's BBH Position: Q1 2026 in Review

Wells Fargo increased its VanEck Biotech ETF (BBH) stake by 12% in Q1 2026, buying an estimated $667K and bringing the position to 32,821 shares worth $6.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

Wells Fargo first reported a position in BBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.7M in Q3 2024. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Wells Fargo held 32,821 shares of VanEck Biotech ETF worth $6.17M as of Q1 2026.
  • Wells Fargo bought 3,464 VanEck Biotech ETF shares in Q1 2026, an estimated $667K.
  • VanEck Biotech ETF made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2427 holding.
  • Wells Fargo first reported a position in VanEck Biotech ETF in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's VanEck Biotech ETF position peaked at $12.7M in Q3 2024.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.